Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China
- PMID: 36743337
- PMCID: PMC9897068
- DOI: 10.2147/IDR.S394071
Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China
Abstract
Purpose: To explore the value of integrating clinical and computed tomography (CT) features to predict multidrug-resistant pulmonary tuberculosis (MDR-PTB).
Patients and methods: The study included 212 patients with MDR-PTB and 180 patients with drug-sensitive pulmonary tuberculosis (DS-PTB) who referred to our institute in China between January 2016 and March 2021. The clinical and CT characteristics were analyzed and compared between both groups. Multivariable logistic regression analysis was performed to identify independent factors that can be used to predict MDR-PTB. Furthermore, 115 patients admitted to another center from January 2019 to January 2022 were included as external validation cohort.
Results: For clinical characteristics, five parameters were significantly different between the two groups (all P < 0.05). With regard to CT features, nine parameters were significantly different between the two groups (all P < 0.05). Multivariable logistic regression analysis using the aforementioned differential features showed that male sex, retreated history, longer duration of previous anti-TB treatment, lower CD4+ T lymphocyte count, thick-walled cavity, centrilobular micronodules and tree-in-bud sign, bronchial stenosis, pleural and pericardial thickening were the most effective variations associated with MDR-PTB with an area under the curve (AUC) of 0.849 and accuracy of 78.6%. Furthermore, the external validation cohort that contains 115 patients obtained an AUC of 0.933 and accuracy of 81.7%.
Conclusion: MDR-PTB and DS-PTB have different clinical and imaging characteristics. A combined model incorporating these differential features can promptly diagnose MDR-PTB and develop subsequent therapeutic strategies.
Keywords: computed tomography; multidrug-resistant tuberculosis; tuberculosis.
© 2023 Li et al.
Conflict of interest statement
Chun-Hua Li and Xiao Fan shared the first authorship for this study. Yong-Mei Li and Qi Li are co-correspondence authors for this study. The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: the Guangzhou computerized tomography study.Quant Imaging Med Surg. 2024 Jan 3;14(1):1010-1021. doi: 10.21037/qims-23-694. Epub 2023 Nov 20. Quant Imaging Med Surg. 2024. PMID: 38223080 Free PMC article.
-
Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: a computerized tomography study with history length matched cases.J Thorac Dis. 2022 Jul;14(7):2522-2531. doi: 10.21037/jtd-22-145. J Thorac Dis. 2022. PMID: 35928612 Free PMC article.
-
Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences.Quant Imaging Med Surg. 2018 Mar;8(2):161-173. doi: 10.21037/qims.2018.03.06. Quant Imaging Med Surg. 2018. PMID: 29675357 Free PMC article.
-
Imaging modalities for pulmonary tuberculosis in children: A systematic review.Eur J Radiol Open. 2022 Dec 30;10:100472. doi: 10.1016/j.ejro.2022.100472. eCollection 2023. Eur J Radiol Open. 2022. PMID: 36624819 Free PMC article. Review.
-
Illustration of a number of atypical computed tomography manifestations of active pulmonary tuberculosis.Quant Imaging Med Surg. 2021 Apr;11(4):1651-1667. doi: 10.21037/qims-20-1323. Quant Imaging Med Surg. 2021. PMID: 33816198 Free PMC article. Review.
Cited by
-
Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: the Guangzhou computerized tomography study.Quant Imaging Med Surg. 2024 Jan 3;14(1):1010-1021. doi: 10.21037/qims-23-694. Epub 2023 Nov 20. Quant Imaging Med Surg. 2024. PMID: 38223080 Free PMC article.
-
Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis.Quant Imaging Med Surg. 2024 Jan 3;14(1):1039-1060. doi: 10.21037/qims-23-1223. Epub 2023 Oct 25. Quant Imaging Med Surg. 2024. PMID: 38223121 Free PMC article. Review.
References
-
- World Health Organization (WHO), Global tuberculosis report 2022. Geneva, Switzerland; 2022. Available from: https://www.who.int/publications/i/item/9789240061729. Accessed January 9, 2023.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials